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INTRODUCTION
Aerococcus viridans, first described in 1953 (1), are catalase-
negative gram-positive cocci that resemble staphylococci by
Gram stain, but have biochemical and growth characteris-
tics of streptococci and enterococci (2-4). It is generally con-
sidered as a contaminant in clinical cultures, but occasional
reports have noted clinically significant roles for this organ-
ism in systemic infections such as bacteremia and endocardi-
tis (5-10). Aerococci appear to be of low virulence and may
be normally pathogenic only in patients with vulnerable con-
ditions (3, 7, 10). No details, however, were given about the
underlying diseases or special risk factors for A. viridans bac-
teremia.
A. viridans was recognized as susceptible to penicillin until
Christensen et al. (11) described a penicillin-resistant strain
isolated from Denmark in 1989. Thereafter, A. viridans infec-
tions showing penicillin resistance have been infrequently
reported (9-13).
The authors isolated multidrug-resistant A. viridans from
blood cultures of 52-yr-old man under the granulocytopenic
condition. As far as we could ascertain from available litera-
tures, this appears to be the first reported case of A. viridans
bacteremia in Korea.
CASE REPORT
A 52-yr-old man was transferred to emergency room of
Wonju Christian Hospital, Wonju, from a local hospital on
June 2, 1997, due to intracerebral hematoma, subarachnoid
and ventricular hemorrhage, and multiple fractures due to
traffic accident.
On presentation to the emergency room, his mental status
was semicomatose. Hematologic findings were: hemoglobin
11.2 g/dL, hematocrit 32.5%, WBC count 11,100/ L (87%
neutrophils, 7% monocytes, and 6% lymphocytes), and
platelet count 186,000/ L. And no organism was detected
from three sets of aerobic and anaerobic blood cultures. On
the fourth day of admission, the patient underwent stereo-
taxic closed drainage of the intracerebral hematoma, and as
of January 21, 1998, he subsequently underwent 4 episodes
of major operations to correct underlying disorders as follows:
internal fixation of leg (July 7, 1997), open reduction of the
mandible fracture (September 5, 1997), ventriculo-peritoneal
shunt for hydrocephalus (December 16, 1997), and revision
of ventriculo-peritoneal shunt (January 21, 1998). Between
the admission and the 492th hospital day, the patient’ s WBC
counts were higher than 5,000/ L, even though he was inter-
mittently treated with antimicrobial agents for pneumonia,
urinary tract infection, and wound infection.
On the 497th hospital day, mild to moderate fever accompa-
nied with leukopenia (total WBC count; 2,470/ L, differen-
tial count; 38% neutrophils, 35% lymphocytes, 10% mono-
cytes, 10% eosinophils, 1% basophils) was noted, and then
two days later three sets of blood cultures were performed due
to sustained low grade fever and low WBC count (1,640/ L).
Blood cultures were done according to our routine proce-
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Penicillin-resistant Aerococcus viridans Bacteremia Associated with
Granulocytopenia
Aerococcus viridans, a catalase-negative gram-positive coccus rarely causing
bacteremia, was isolated from blood cultures of a 52-yr-old man under the gran-
ulocytopenic condition. The isolate showed the typical characteristics of A. viri-
dans, i.e., tetrad arrangements in gram stain, positive pyrrolidonyl aminopeptidase
(PYR) and negative leucine aminopeptidase (LAP) reactions, and no growth at
45℃. The isolate was revealed to be highly resistant to penicillin, erythromycin,
clindamycin, and ceftriaxone, although most strains of A. viridans isolated from
the previously reported patients were susceptible to penicillin and other common-
ly used antibiotics. Even though A. viridans is rarely associated with human infec-
tions, it could be a potential causative agent of bacteremia, especially in immuno-
compromised patients.
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dure, i.e., 10 mL of venous blood was drawn and inoculated
into each of 40 mL of aerobic bottle (BACTEC Plus Aero-
bic/F, Becton Dickinson Diagnostic Instrument Systems,
U.S.A.) of the BACTEC 9240 automated blood culture sys-
tem (Becton Dickinson Diagnostic Instrument Systems,
U.S.A.) and 50 mL anaerobic thioglycollate broth medium
(Difco, U.S.A.). All of three sets for aerobic blood culture
grew gram-positive cocci after 4 days of incubation, which
were later identified as A. viridans. No anaerobic organism
was detected from anaerobic blood cultures. According to
the verbal report as  “gram positive cocci seen on Gram stain
of blood cultures” , the neurosurgeon replaced ceftezole used
for urinary tract infection with pefloxacin and teicoplanin.
Then, total WBC count showed a increasing trend, and recov-
ered to 6,660/ L on the 505th hospital day. At that time,
the patient became afebrile. Antimicrobial susceptibility test
by National Committee for Clinical Laboratory Standards
(NCCLS) recommended disk diffusion method for nonpneu-
mococcal Streptococcus category (14) showed that the isolate
was susceptible to vancomycin and chloramphenicol, but
resistant to penicillin, erythromycin, clindamycin, ceftriax-
one, and ofloxacin. Minimal inhibitory concentrations (MIC)
to penicillin G, erythromycin, tetracycline (Sigma Chemical,
U.S.A.), ceftriaxone (Roche, Switzerland), vancomycin (Dae-
woong Lilly, Korea), chloramphenicol (Chongkundang, Ko-
rea), and clindamycin (Korea Upjohn, Korea) were obtained
by the NCCLS agar dilution method (15). Mueller-Hinton
agar (Oxoid, U.K.) with 5% defibrinated sheep blood was
used for the agar dilution test. Inocula were prepared by
suspending colonies in tryptic soy broth (Difco, U.S.A.) to
form approximately 10
4 CFU/spot when inoculated with a
Steers replicator (Craft Machine, U.S.A.). Inoculated plates
were incubated at 35℃ in air for 22-24 hr and the results
were as follows: penicillin G, ceftriaxone, erythromycin, and
clindamycin were ≥256 g/mL,  vancomycin  0.25 g/mL,
tetracycline 0.5  g/mL, and chloramphenicol was 16  g/ mL.
To determine susceptibilities to seven antimicrobial agents
tested, interpretative criteria for nonpneumococcal Strepto-
coccus category of NCCLS (15) were used.
For the identification of the isolate from blood culture, con-
ventional biochemical tests (2) and API 20 Strep and API
rapid ID 32 Strep (bioMerieux SA, Marcy l′ Etoile, France) were
used. The characteristic test results were as follows: gram-pos-
itive cocci in tetrads and pairs on Gram stain, negative cata-
lase reaction, no agglutination against group D streptococ-
cal antiserum, poor growth on blood agar plate by anaerobic
incubation, no growth on 45℃, small  -hemolytic colonies
on blood agar, growth in 6.5% NaCl, positive PYR reac-
tion, and negative LAP reaction. The microorganism was
subcultured in Todd-Hewitt broth (Difco, U.S.A.), and the
repeat Gram stain demonstrated the characteristic gram-
positive cocci, predominantly in tetrads and pairs. Other
biochemical test results are shown in Table 1. API 20 Strep
and API rapid ID 32 Strep identified the isolate as A. viri-
dans (probabilities, 99.6% [bionumber, 4500410] and
99.9% [bionumber, 21630101150], respectively).
DISCUSSION
A. viridans is frequently isolated from two divergent sources:
as a common airborne organism in hospital environments
and as a marine organism causing a fatal disease in lobster
(16). In human, aerococci can be found in a very small num-
ber as indigenous inhabitants in the upper respiratory tract
and on the skin of normal persons (1). This organism is gen-
erally saprophytic and rarely has been encountered as a human
pathogen (2, 9, 10). It was first described as a potential human
pathogen in 1967 (5). Since then, it has been reported as the
causative agent of meningitis (8), endocarditis (9), bacteremia
(10), or of other infections such as urinary tract infection,
septic arthritis, and wound infection (2).
Although the pathogenicity and virulence of A. viridans
have not been well-established, infections due to this organ-
ism presumably seem to occur in previously damaged tissues
or may be of nosocomial in association with a prolonged hos-
pitalization, antibiotic treatment, invasive procedures, pres-
ence of foreign bodies, or neutropenic state (2, 3, 7, 10). Kern
and Vanek (7) suggested that both granulocytopenia and oral
mucositis be the major risk factors for aerococcal bacteremia.
These observations together with our patient’ s underlying
conditions suggest that granulocytopenia be one of the risk
factors of A. viridans bacteremia. Recently, Swanson et al.
(10) also described that A. viridans might be a significant
pathogen in patients with functional asplenia, in that the
organism is encapsulated with an acidic polysaccharide, and
the strains with heavier encapsulation are more virulent (17).
*Adapted from references 2 and 3.
�-, negative or no growth; +, positive or growth; V, variable.
Tests A. viridans* Isolate
Gram stain Tetrads, pairs Tetrads, pairs
Relation to oxygen Microaerophilic Microaerophilic
Hemolysis Alpha Alpha
Catalase -
� -
Bile esculin V +
Growth in 6.5% NaCl + +
Pyrrolidonyl aminopeptidase + +
Leucine aminopeptidase --
Growth at 45℃ --
Arginine dihydrolase --
Hippurate hydrolysis V -
Acid from glucose + +
lactose + +
trehalose + +
sorbose --
Voges-Proskauer reaction --
Table 1. Characteristics of A. viridans isolate
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Limited are the data in the literature on the antimicrobial
susceptibility of A. viridans, because this organism has been
infrequently associated with human infections, and is usual-
ly susceptible to penicillin. In addition, standardized suscep-
tibility testing methods and interpretative criteria are not
available for aerococci, although most investigators have used
the nonpneumococcal Streptococcus category of the NCCLS.
As revealed by a cluster of sporadic reports, antimicrobial
susceptibility patterns of A. viridans have been rapidly changed
as follows; until the late 1980s, this organism had been report-
ed as susceptible to the most commonly used antibiotics, but
recent studies have documented that A. viridans have shown
resistance not only to penicillin but also to chloramphenicol
and the quinolones as well (7, 9, 12, 18). In 1987, Kern
and Vanek (7) described that two aerococci isolated from
blood cultures were sensitive to penicillin G and piperacillin
but resistant to fluoroquinolone and netilmicin given orally
for prophylaxis. In 1996, Swanson et al. (10) reported a case
of penicillin-resistant A. viridans (penicillin MIC, 0.5  g/
mL) bacteremia in a child who was receiving prophylactic
penicillin. These observations suggest that drug resistance
of A. viridans could be induced by selective pressure by pro-
longed antibiotic use.
Augustine et al. (9) reported a case of endocarditis caused
by A. viridans with multidrug resistance, i.e., resistance to
penicillin, ampicillin, cefotaxime, gentamicin, and interme-
diate resistant to ciprofloxacin, but they did not discussed
on MICs. According to the antimicrobial susceptibility data
of 30 aerococcal isolates obtained from Centers for Disease
Control and Prevention (12), the MICs for 9 strains were
0.5  g or more of penicillin per mL, with MICs for 5 strains
being more than 1  g/mL; therefore, approximately 46% of
aerococci tested were either relatively resistant or resistant
to penicillin. Moreover, Christensen et al. (13) recently doc-
umented that penicillin resistance should be the peculiar
characteristics of A. viridans capable of differentiating it from
Aerococcus-like organisms.
Since A. viridans is usually recognized as susceptible to
penicillin, the treatment protocol for aerococcal endocarditis
is similar to that for endocarditis caused by penicillin-suscep-
tible streptococci (19). Although penicillin - or multidrug-resis-
tant A. viridans strains have been occasionally isolated from
clinical specimens as documented by some authors and us,
optimal treatment of systemic infections caused by the
penicillin-resistant A. viridans has not been established yet.
In conclusion, even though A. viridans is rarely associated
with human infections, it could be a potential causative agent
of bacteremia, if A. viridans is isolated from the multiple set
of blood cultures especially in immunocompromised patients,
effective antibiotics on the basis of antibiogram thereof should
be administered. Further investigations are needed to estab-
lish the optimal treatment for this pathogen.
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